Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes.

ABSTRACT:

Background

FIND, the global alliance for diagnostics, identified the nonmarket-approved continuous glucose monitoring (CGM) system, FiberSense system (FBS), as a potential device for use in low- and middle-income countries. Together with two market-approved, factory-calibrated CGM systems, namely, the FreeStyle Libre 2 (FL2) and the GlucoRx AiDEX (ADX), the FBS was subjected to a clinical performance evaluation.

Methods

Thirty adult participants with type 1 diabetes were enrolled. The study was mainly conducted at home, with three in-clinic sessions conducted over the study period of 28 days. Comparator measurements were collected from capillary samples, using a high-quality blood glucose monitoring system.

Results

Data from 31, 70, and 78 sensors of FBS, FL2, and ADX

SUBMITTER: Kolle J 

PROVIDER: S-EPMC11529083 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature